Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix Tetra Safety and Immunogenicity in Older Adults in India
NCT05648357Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2023
- Primary completion
- Feb 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Fluarix Quadrivalent in influenza, sponsored by GSK. Started Dec 2023; status: completed.
02
Drugs
Fluarix Quadrivalent
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05648357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05648357.